vs
Side-by-side financial comparison of PHOTRONICS INC (PLAB) and Protagonist Therapeutics, Inc (PTGX). Click either name above to swap in a different company.
PHOTRONICS INC is the larger business by last-quarter revenue ($210.4M vs $170.6M, roughly 1.2× Protagonist Therapeutics, Inc). Protagonist Therapeutics, Inc runs the higher net margin — 77.2% vs 10.9%, a 66.3% gap on every dollar of revenue. On growth, Protagonist Therapeutics, Inc posted the faster year-over-year revenue change (184.4% vs -5.5%). Protagonist Therapeutics, Inc produced more free cash flow last quarter ($182.8M vs $25.2M).
Photronics, Inc. is an American semiconductor photomask manufacturer. It was the third largest photomask supplier globally as of 2009. Photronics is a member of the eBeam Initiative.
Protagonist Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing novel peptide-based targeted therapies for unmet medical needs, primarily covering gastrointestinal disorders, inflammatory diseases and rare disease indications. Its lead product candidates target inflammatory bowel disease and other chronic immune-related conditions, with operations spanning global R&D and partnership collaborations.
PLAB vs PTGX — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2024
| Metric | | |
|---|---|---|
| Revenue | $210.4M | $170.6M |
| Net Profit | $22.9M | $131.7M |
| Gross Margin | 33.7% | — |
| Operating Margin | 22.9% | 74.3% |
| Net Margin | 10.9% | 77.2% |
| Revenue YoY | -5.5% | 184.4% |
| Net Profit YoY | -32.4% | 381.7% |
| EPS (diluted) | $0.39 | $2.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | $210.4M | — | ||
| Q2 25 | $211.0M | — | ||
| Q1 25 | $212.1M | — | ||
| Q4 24 | $222.6M | $170.6M | ||
| Q3 24 | $211.0M | — | ||
| Q2 24 | $217.0M | — | ||
| Q1 24 | $216.3M | $255.0M | ||
| Q4 23 | $227.5M | — |
| Q3 25 | $22.9M | — | ||
| Q2 25 | $8.9M | — | ||
| Q1 25 | $42.9M | — | ||
| Q4 24 | $33.9M | $131.7M | ||
| Q3 24 | $34.4M | — | ||
| Q2 24 | $36.3M | — | ||
| Q1 24 | $26.2M | $207.3M | ||
| Q4 23 | $44.6M | — |
| Q3 25 | 33.7% | — | ||
| Q2 25 | 36.9% | — | ||
| Q1 25 | 35.6% | — | ||
| Q4 24 | 37.0% | — | ||
| Q3 24 | 35.6% | — | ||
| Q2 24 | 36.5% | — | ||
| Q1 24 | 36.6% | — | ||
| Q4 23 | 37.3% | — |
| Q3 25 | 22.9% | — | ||
| Q2 25 | 26.4% | — | ||
| Q1 25 | 24.6% | — | ||
| Q4 24 | 25.1% | 74.3% | ||
| Q3 24 | 24.7% | — | ||
| Q2 24 | 25.8% | — | ||
| Q1 24 | 26.6% | 80.9% | ||
| Q4 23 | 28.5% | — |
| Q3 25 | 10.9% | — | ||
| Q2 25 | 4.2% | — | ||
| Q1 25 | 20.2% | — | ||
| Q4 24 | 15.2% | 77.2% | ||
| Q3 24 | 16.3% | — | ||
| Q2 24 | 16.7% | — | ||
| Q1 24 | 12.1% | 81.3% | ||
| Q4 23 | 19.6% | — |
| Q3 25 | $0.39 | — | ||
| Q2 25 | $0.15 | — | ||
| Q1 25 | $0.68 | — | ||
| Q4 24 | $0.54 | $2.01 | ||
| Q3 24 | $0.55 | — | ||
| Q2 24 | $0.58 | — | ||
| Q1 24 | $0.42 | $3.26 | ||
| Q4 23 | $0.71 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $575.8M | $418.9M |
| Total DebtLower is stronger | $16.0K | — |
| Stockholders' EquityBook value | $1.1B | $675.3M |
| Total Assets | $1.8B | $744.7M |
| Debt / EquityLower = less leverage | 0.00× | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $575.8M | — | ||
| Q2 25 | $558.4M | — | ||
| Q1 25 | $642.2M | — | ||
| Q4 24 | $640.7M | $418.9M | ||
| Q3 24 | $606.4M | — | ||
| Q2 24 | $559.9M | — | ||
| Q1 24 | $521.5M | $322.6M | ||
| Q4 23 | $512.2M | — |
| Q3 25 | $16.0K | — | ||
| Q2 25 | $19.0K | — | ||
| Q1 25 | $21.0K | — | ||
| Q4 24 | $25.0K | — | ||
| Q3 24 | $28.0K | — | ||
| Q2 24 | $2.5M | — | ||
| Q1 24 | $2.7M | — | ||
| Q4 23 | $18.0M | — |
| Q3 25 | $1.1B | — | ||
| Q2 25 | $1.1B | — | ||
| Q1 25 | $1.1B | — | ||
| Q4 24 | $1.1B | $675.3M | ||
| Q3 24 | $1.1B | — | ||
| Q2 24 | $1.0B | — | ||
| Q1 24 | $1.0B | $560.4M | ||
| Q4 23 | $975.0M | — |
| Q3 25 | $1.8B | — | ||
| Q2 25 | $1.7B | — | ||
| Q1 25 | $1.7B | — | ||
| Q4 24 | $1.7B | $744.7M | ||
| Q3 24 | $1.6B | — | ||
| Q2 24 | $1.6B | — | ||
| Q1 24 | $1.6B | $629.3M | ||
| Q4 23 | $1.5B | — |
| Q3 25 | 0.00× | — | ||
| Q2 25 | 0.00× | — | ||
| Q1 25 | 0.00× | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | 0.00× | — | ||
| Q2 24 | 0.00× | — | ||
| Q1 24 | 0.00× | — | ||
| Q4 23 | 0.02× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $50.1M | $184.2M |
| Free Cash FlowOCF − Capex | $25.2M | $182.8M |
| FCF MarginFCF / Revenue | 12.0% | 107.1% |
| Capex IntensityCapex / Revenue | 11.8% | 0.8% |
| Cash ConversionOCF / Net Profit | 2.19× | 1.40× |
| TTM Free Cash FlowTrailing 4 quarters | $64.5M | $101.7M |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $50.1M | — | ||
| Q2 25 | $31.5M | — | ||
| Q1 25 | $78.5M | — | ||
| Q4 24 | $68.4M | $184.2M | ||
| Q3 24 | $75.1M | — | ||
| Q2 24 | $76.5M | — | ||
| Q1 24 | $41.5M | $-27.4M | ||
| Q4 23 | $106.6M | — |
| Q3 25 | $25.2M | — | ||
| Q2 25 | $-29.1M | — | ||
| Q1 25 | $43.3M | — | ||
| Q4 24 | $25.2M | $182.8M | ||
| Q3 24 | $50.7M | — | ||
| Q2 24 | $56.5M | — | ||
| Q1 24 | $-1.8M | $-27.7M | ||
| Q4 23 | $54.1M | — |
| Q3 25 | 12.0% | — | ||
| Q2 25 | -13.8% | — | ||
| Q1 25 | 20.4% | — | ||
| Q4 24 | 11.3% | 107.1% | ||
| Q3 24 | 24.0% | — | ||
| Q2 24 | 26.0% | — | ||
| Q1 24 | -0.8% | -10.9% | ||
| Q4 23 | 23.8% | — |
| Q3 25 | 11.8% | — | ||
| Q2 25 | 28.7% | — | ||
| Q1 25 | 16.6% | — | ||
| Q4 24 | 19.4% | 0.8% | ||
| Q3 24 | 11.6% | — | ||
| Q2 24 | 9.2% | — | ||
| Q1 24 | 20.0% | 0.1% | ||
| Q4 23 | 23.1% | — |
| Q3 25 | 2.19× | — | ||
| Q2 25 | 3.55× | — | ||
| Q1 25 | 1.83× | — | ||
| Q4 24 | 2.02× | 1.40× | ||
| Q3 24 | 2.18× | — | ||
| Q2 24 | 2.11× | — | ||
| Q1 24 | 1.59× | -0.13× | ||
| Q4 23 | 2.39× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PLAB
| High End Integrated Circuits | $53.6M | 25% |
| High End Flat Panel Displays | $53.5M | 25% |
| KR | $43.7M | 21% |
| Other | $42.1M | 20% |
| Mainstream Flat Panel Displays | $9.1M | 4% |
| Transferred At Point In Time | $8.4M | 4% |
PTGX
Segment breakdown not available.
